Carcelen, Andrea C Prosperi, Christine Mutembo, Simon Chongwe, Gershom Mwansa, Francis D Ndubani, Phillimon Simulundu, Edgar Chilumba, Innocent Musukwa, Gloria Thuma, Phil
...
Published in
Human vaccines & immunotherapeutics
With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesit...
Heppe Montero, Marco Gil-Prieto, Ruth Walter, Stefan Aleixandre Blanquer, Fernando Gil De Miguel, Ángel
Published in
Human vaccines & immunotherapeutics
Bronchiolitis represents a heavy burden of disease in children under 2 years of age in our society due to the high infectivity of the Respiratory Syncytial Virus [RSV] and the vulnerability of the youngest children.The objective of this retrospective epidemiological study was to show the burden of severe bronchiolitis in Spain through population-ba...
Saddik, Basema Al-Bluwi, Najlaa Shukla, Ankita Barqawi, Hiba Alsayed, Hawra Ali Hussain Sharif-Askari, Narjes Saheb Temsah, Mohamad-Hani Bendardaf, Riyad Hamid, Qutayba Halwani, Rabih
...
Published in
Human vaccines & immunotherapeutics
Acceptance of COVID-19 vaccine among health-care workers (HCWs) is crucial for controlling the pandemic and ensuring HCW and patient safety. Information on the acceptance of different COVID-19 vaccines is lacking. Despite the United Arab Emirates (UAE) having vaccinated most of its population, vaccine acceptance still raises concerns. This study ex...
MacDonald, Shannon E Palichuk, Airlie Slater, Linda Tripp, Hailey Reifferscheid, Laura Burton, Catherine
Published in
Human vaccines & immunotherapeutics
Immunocompromised children are at increased risk of severe illness from vaccine-preventable infections. However, inadequate vaccine coverage remains a concern. This scoping review sought to determine the current state of knowledge regarding vaccine coverage of immunocompromised children. Bibliographic databases were searched for primary research fr...
Behera, Priyamadhaba Singh, Arvind Kumar Subba, Sonu Hangma Mc, Arjun Sahu, Dinesh Prasad Chandanshive, Pradnya Dilip Pradhan, Somen Kumar Parida, Swayam Pragyan Mishra, Abhisek Patro, Binod Kumar
...
Published in
Human vaccines & immunotherapeutics
India approved COVID-19 vaccine called Covaxin, developed by the Indian Council of Medical Research and Bharat Biotech Ltd. The primary objective of the study was to estimate the effectiveness of Covaxin in preventing breakthrough SARS-CoV-2 infection in healthcare workers (HCWs). A test-negative matched case-control study was conducted among HCWs ...
Omeish, Haya Najadat, Angam Al-Azzam, Sayer Tarabin, Nada Abu Hameed, Amer Al-Gallab, Neebal Abbas, Hadeel Rababah, Lana Rabadi, Majd Karasneh, Reema
...
Published in
Human vaccines & immunotherapeutics
Concerns about the safety and side effects of coronavirus SARS CoV2 vaccines have been raised among many communities worldwide. The aim of this study was to describe the side effects reported by vaccinated individuals in Jordan. A cross-sectional survey was used to recruit responses from participants who were vaccinated with either one dose or both...
Ilogu, Laura Chinenye Lugovska, Olga Vojtek, Ivo Prugnola, Anna Callegaro, Andrea Mazzilli, Sara Van Damme, Pierre
Published in
Human vaccines & immunotherapeutics
Young adults are the future vaccine decision-makers as parents or health-care professionals. To understand their attitudes and behaviors toward vaccination, we conducted a cross-sectional survey of 2079 students attending the University of Antwerp, Belgium and the University of Pisa, Italy. Principal component analysis was used to investigate assoc...
Shi, Chenjuan Tian, Li Zheng, Wenwen Zhu, Yelei Sun, Peilu Liu, Lele Liu, Wenkai Song, Yanyan Xia, Xianzhu Xue, Xianghong
...
Published in
Emerging microbes & infections
Three or four intramuscular doses of the inactivated human rabies virus vaccines are needed for pre- or post-exposure prophylaxis in humans. This procedure has made a great contribution to prevent human rabies deaths, which bring huge economic burdens in developing countries. Herein, a recombinant adeno-associated virus serotype 9, AAV9-RABVG, harb...
Fernandes, Queenie Inchakalody, Varghese Philipose Merhi, Maysaloun Mestiri, Sarra Taib, Nassiba Moustafa Abo El-Ella, Dina Bedhiafi, Takwa Raza, Afsheen Al-Zaidan, Lobna Mohsen, Mona O
...
Published in
Annals of medicine
The emergence of novel and evolving variants of SARS-CoV-2 has fostered the need for change in the form of newer and more adaptive diagnostic methods for the detection of SARS-CoV-2 infections. On the other hand, developing rapid and sensitive diagnostic technologies is now more challenging due to emerging variants and varying symptoms exhibited am...
Dadras, Omid SeyedAlinaghi, SeyedAhmad Karimi, Amirali Shamsabadi, Ahmadreza Mahdiabadi, Sara Mohammadi, Parsa Amiri, Ava Shojaei, Alireza Pashaei, Zahra Mirzapour, Pegah
...
Published in
Human vaccines & immunotherapeutics
COVID-19 vaccines emerged as a worldwide hope to contain the pandemic. However, many people are still hesitant to receive these vaccines. We aimed to systematically review the public knowledge, perception, and acceptability of COVID-19 vaccines in the Middle East and North Africa (MENA) countries and the predictors of vaccine acceptability in this...
